Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1827 News Items found In the Clinic Acupuncture May Ease ‘Brain Fog’ in Breast Cancer Survivors, Trial Shows Friday, December 12, 2025 A phase 2 randomized clinical trial at MSK has found that acupuncture can improve cognitive abilities in breast cancer survivors experiencing "brain fog." Article FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment Friday, December 12, 2025 Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL). Article Imlunestrant With or Without Abemaciclib Effective in Treating ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy Friday, December 12, 2025 Read about a new treatment for people with some ER+, HER2- advanced breast cancers. Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients Thursday, December 11, 2025 A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer. Article Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer Wednesday, December 10, 2025 Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer. Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts Monday, December 8, 2025 Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research. MSK Research Reveals Connection Between Diet and Cancer Monday, December 8, 2025 Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk. Clinical Update CAR T Cell Therapy for Light Chain (AL) Amyloidosis Achieves Strong Results Sunday, December 7, 2025 Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis. Article New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically Sunday, December 7, 2025 Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma. New Treatment for Relapsed Follicular Lymphoma Approved by FDA After MSK-Led Clinical Trial Sunday, December 7, 2025 A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment